Tanya Wallace

Tanya Wallace, Ph.D. is a program director in the Center for Neuroscience and Metabolic Diseases in SRI Biosciences.  In this role, she directs the Translational Neuroscience Research Program, which focuses on designing and conducting cognitive studies that effectively translate into clinical applications to facilitate drug development for cognitive impairing diseases (e.g., Alzheimer’s disease, schizophrenia). 

Prior to joining SRI, Wallace was a principal research scientist in Neuroscience at Roche Pharmaceuticals and a senior research investigator at Bristol Myers-Squibb.  She has over 10 years of professional experience in Neuroscience drug discovery and has led pharmacology efforts that have spanned preclinical and clinical investigations. 

Wallace received her B.S. in Biology from Ohio State University and a Ph.D. in Neuroscience from the University of Cincinnati. She completed postdoctoral research training in the Division of Molecular Psychiatry at Yale University.